Search

everythinglearnresearchcommunity

for

Search:↓

PCOS is a common hormonal disorder in women that can lead to serious health problems.

Better hair loss models needed for research.

The conference presented findings on how vitamin D levels, genetic factors, and lifestyle choices like smoking and yoga affect various health conditions and diseases.

Testosterone therapy can improve sexual function in women but long-term safety is unclear.

IGF-1 from human placenta helps hair grow.

Androgen replacement therapy can improve libido and mood in women with severe androgen deficiency, but more research is needed on its long-term safety.

Cell transplantation faces challenges in genitourinary reconstruction, but alternative tissue sources and microencapsulation show promise.

Cyproterone acetate may cause liver cancer at high doses, but is considered safe at recommended doses for approved uses.

Low vitamin D and ferritin levels are linked to female hair loss.

PCOS treatment focuses on lifestyle changes and specific medications to manage symptoms and complications.

Sex steroids affect the MafB gene differently in male and female hamsters.

The research found that measuring androgens in urine can give extra information about body metabolism and is linked to androgen levels in the blood, especially in young girls.

Blocking glucocorticoid receptors improves glucose metabolism in a PCOS mouse model.

Hair cortisol may be a good indicator of recent mood in people with bipolar disorder.

Hair glycation could be a reliable non-invasive indicator of blood glucose control, but its use is limited by factors like sample collection and hair treatments.

The enzyme 5α-reductase is important for proper blood vessel development during the fertility-related transformation of the uterus lining.

The May issue discussed publishing agreements and four studies on cholesterol in hair, cancer cell changes, hormones in the uterus, and skin protein effects.

The article concludes that better diagnosis and management of Polycystic Ovarian Syndrome are needed to improve women's health and prevent related diseases.

PCOS is a genetic disorder affecting women's reproductive health, with treatments focused on symptoms like insulin resistance and fertility.

The conclusion is that a more comprehensive and precise approach is needed for diagnosing PCOS to address its broader health risks.

The model and estimator can predict drug exposure in kidney transplant patients well.

Swedish men with the E213 A-allele of the androgen receptor have a lower risk of prostate cancer.

Chrousos Syndrome is caused by mutations that make the body less sensitive to glucocorticoids, leading to various symptoms and requiring high-dose treatment.

The method reliably profiles eicosanoids and shows epitestosterone reduces their levels, similar to common anti-inflammatory drugs.

The document concludes that treatments for female hair loss and excess body hair are available, but managing expectations is important.

The document concludes that accurate diagnosis and management of PCOS are crucial due to its associated health risks.

The document concludes that early diagnosis and treatment of PCOS in teenagers is important for managing symptoms and preventing long-term health problems.

The meeting highlighted the genetic basis of female pattern hair loss and various skin health insights.

Testosterone therapy can help postmenopausal women with low sexual desire but needs more safety research and should be used with estrogen therapy.

Testosterone therapy can help with androgen deficiency in women but should be used with caution and monitoring due to potential risks.